Drug Type Bispecific antibody |
Synonyms DB 001, DB001 |
Target |
Mechanism HER2 exon 20 inhibitors(ERBB2 Exon 20 Mutation inhibitors), PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | SG | Dotbio Pte Ltd.Startup | - |